The average score of the Diabetes Treatment Satisfaction Questionnaire22 was 26.4 (5.6) at baseline, 26.9 (5.7) after sensor-augmented pump therapy, and 28.2 (5.5) after automated insulin delivery (Supplementary Appendix). The gene discussed is INS; the disease is diabetes mellitus.